Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

LLM 2021 | Thromboprophylaxis in patients with VWD and COVID-19

Suchitra Acharya, MD, MBBS, Northwell Health, New Hyde Park, New York, NY, discusses the use of prophylactic anticoagulants in patients with rare bleeding disorders infected with COVID-19. Adults with COVID-19 are at a higher risk of developing thrombosis and are consequently administered a thromboprophylaxis. For patients with rare bleeding disorders including type III von Willebrand disorder, replacement factor concentrates are necessary to stabilize factor levels to safely administer the prophylactic anticoagulant. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.